Memory defect induced by beta-amyloid plus glutamate receptor agonist is alleviated by catalpol and donepezil through different mechanisms

Brain Research

Volumn 1441, Issue , 2012, Pages 27-37

  Xia, Zhiming ^a   Zhang, Rui ^a   Wu, Pingping ^a   Xia, Zongqin ^a   Hu, Yaer ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

A ; BDNF; Catalpol; ChAT activity; Donepezil; M receptor

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; BRAIN DERIVED NEUROTROPHIC FACTOR; CATALPOL; CHOLINE ACETYLTRANSFERASE; DONEPEZIL; GLUTAMATE RECEPTOR AGONIST; MESSENGER RNA; MUSCARINIC RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOREBRAIN; LEARNING; MAZE TEST; MEMORY; MEMORY DISORDER; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; EXCITATORY AMINO ACID AGONISTS; FEMALE; INDANS; IRIDOID GLUCOSIDES; MEMORY DISORDERS; MICE; MICE, INBRED ICR; PEPTIDE FRAGMENTS; PIPERIDINES; PROTEIN BINDING; RANDOM ALLOCATION; RECEPTORS, GLUTAMATE;

ANIMALIA; MUS; REHMANNIA GLUTINOSA;

EID: 84862814601     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.01.008     Document Type: Article

References (44)

1. S. Arancibia, M. Silhol, F. Mouliere, J. Meffre, I. Hollinger, T. Maurice, and L. Tapia-Arancibia Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats Neurobiol. Dis. 31 2008 316 326
2. D.S. Auld, T.J. Kornecook, S. Bastianetto, and R. Quirion Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies Prog. Neurobiol. 68 2002 209 245 (Pubitemid 35346805)
3. R.T. Bartus On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis Exp. Neurol. 163 2000 495 529 (Pubitemid 30399100)
4. R.T. Bartus, R.L. Dean III, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
5. K. Blennow, M.J. de Leon, and H. Zetterberg Alzheimer's disease Lancet 368 2006 387 403 (Pubitemid 44108123)
6. R. Blum, and A. Konnerth Neurotrophin-mediated rapid signaling in the central nervous system: mechanisms and functions Physiology (Bethesda) 20 2005 70 78 (Pubitemid 40363373)
7. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N.A. Castello, F.J. Muller, J.F. Loring, T.R. Yamasaki, W.W. Poon, K.N. Green, and F.M. LaFerla Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 106 2009 13594 13599
8. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, and K.H. Ashe Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function Nat. Neurosci. 8 2005 79 84 (Pubitemid 41236735)
9. P. De Bartolo, F. Gelfo, L. Mandolesi, F. Foti, D. Cutuli, and L. Petrosini Effects of chronic donepezil treatment and cholinergic deafferentation on parietal pyramidal neuron morphology J. Alzheimers Dis. 17 2009 177 191
10. H. Dong, C.M. Yuede, C.A. Coughlan, K.M. Murphy, and J.G. Csernansky Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease Brain Res. 1303 2009 169 178
11. K.I. Erickson, R.S. Prakash, M.W. Voss, L. Chaddock, S. Heo, M. McLaren, B.D. Pence, S.A. Martin, V.J. Vieira, J.A. Woods, E. McAuley, and A.F. Kramer Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume J. Neurosci. 30 2010 5368 5375
12. F. Fonnum Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities Biochem. J. 115 1969 465 472
13. F. Fumagalli, G. Racagni, and M.A. Riva The expanding role of BDNF: a therapeutic target for Alzheimer's disease? Pharmacogenomics J. 6 2006 8 15 (Pubitemid 43118305)
14. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
15. K.H. Haug, I.L. Bogen, H. Osmundsen, I. Walaas, and F. Fonnum Effects on cholinergic markers in rat brain and blood after short and prolonged administration of donepezil Neurochem. Res. 30 2005 1511 1520 (Pubitemid 41813715)
16. C.M. Hernandez, D.A. Gearhart, V. Parikh, E.J. Hohnadel, L.W. Davis, M.L. Middlemore, S.P. Warsi, J.L. Waller, and A.V. Terry Jr. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats J. Pharmacol. Exp. Ther. 316 2006 679 694 (Pubitemid 43130995)
17. Y. Hu, Z. Xia, Q. Sun, A. Orsi, and D. Rees A new approach to the pharmacological regulation of memory: sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models Brain Res. 1060 2005 26 39 (Pubitemid 41483586)
18. Y. Hu, Z. Wang, R. Zhang, P. Wu, Z. Xia, A. Orsi, and D. Rees Regulation of M1-receptor mRNA stability by smilagenin and its significance in improving memory of aged rats Neurobiol. Aging 31 2010 1010 1019
19. Y. Ito, M. Ito, N. Takagi, H. Saito, and K. Ishige Neurotoxicity induced by amyloid beta-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-l-cysteine, a garlic compound Brain Res. 985 2003 98 107 (Pubitemid 37272056)
20. J.Y. Koh, L.L. Yang, and C.W. Cotman Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage Brain Res. 533 1990 315 320 (Pubitemid 20377714)
21. S. Kotani, T. Yamauchi, T. Teramoto, and H. Ogura Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats Neuroscience 142 2006 505 514 (Pubitemid 44415335)
22. Q.F. Liu, Z.Q. Xia, Q.X. Sun, and Y.E. Hu Dual directional regulation of catalpol on the imbalance of beta-adrenergic receptor and M cholinergic receptor [in Chinese] J. Shanghai Jiaotong Univ. (Med. Sci.) 27 2007 1432 1434
23. S. Liu, Y.E. Hu, and Z.Q. Xia Changes of memory and M receptor injection of Aβ(25-35) into basal ganglion region of forebrain and effect of catalpol [in Chinese] J. Shanghai Jiaotong Univ. (Med. Sci.) 27 2007 945 948
24. F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, and M. Kivipelto Alzheimer's disease: clinical trials and drug development Lancet Neurol. 9 2010 702 716
25. A. Martorana, Z. Esposito, and G. Koch Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? CNS Neurosci. Ther. 16 2010 235 245
26. M.P. Mattson, B. Cheng, D. Davis, K. Bryant, I. Lieberburg, and R.E. Rydel Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity J. Neurosci. 12 1992 376 389
27. K. Morimoto, K. Yoshimi, T. Tonohiro, N. Yamada, T. Oda, and I. Kaneko Co-injection of beta-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons Neuroscience 84 1998 479 487 (Pubitemid 28122912)
28. Z. Muresan, and V. Muresan Neuritic deposits of amyloid-beta peptide in a subpopulation of central nervous system-derived neuronal cells Mol. Cell. Biol. 26 2006 4982 4997 (Pubitemid 43955813)
29. A.H. Nagahara, D.A. Merrill, G. Coppola, S. Tsukada, B.E. Schroeder, G.M. Shaked, L. Wang, A. Blesch, A. Kim, J.M. Conner, E. Rockenstein, M.V. Chao, E.H. Koo, D. Geschwind, E. Masliah, A.A. Chiba, and M.H. Tuszynski Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease Nat. Med. 15 2009 331 337
30. S. Nakamura, N. Murayama, T. Noshita, R. Katsuragi, and T. Ohno Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801 Eur. J. Pharmacol. 548 2006 115 122 (Pubitemid 44404130)
31. J.T. O'Brien, and A. Burns Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology J. Psychopharmacol. 25 2011 997 1019
32. T. Ondrejcak, I. Klyubin, N.W. Hu, A.E. Barry, W.K. Cullen, and M.J. Rowan Alzheimer's disease amyloid beta-protein and synaptic function Neuromolecular Med. 12 2010 13 26
33. S. Peng, J. Wuu, E.J. Mufson, and M. Fahnestock Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease J. Neurochem. 93 2005 1412 1421 (Pubitemid 40853264)
34. R.D. Price, S.A. Milne, J. Sharkey, and N. Matsuoka Advances in small molecules promoting neurotrophic function Pharmacol. Ther. 115 2007 292 306 (Pubitemid 47042910)
35. H.W. Querfurth, and F.M. LaFerla Alzheimer's disease N. Engl. J. Med. 362 2010 329 344
36. C.S. Rex, J.C. Lauterborn, C.Y. Lin, E.A. Kramar, G.A. Rogers, C.M. Gall, and G. Lynch Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor J. Neurophysiol. 96 2006 677 685 (Pubitemid 44155208)
37. M.W. Riepe Cholinergic treatment: what are the early neuropathological targets? Eur. J. Neurol. 12 Suppl 3 2005 3 9 (Pubitemid 41495144)
38. R. Schliebs, and T. Arendt The significance of the cholinergic system in the brain during aging and in Alzheimer's disease J. Neural Transm. 113 2006 1625 1644 (Pubitemid 44657659)
39. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791 (Pubitemid 35231524)
40. J. Soule, E. Messaoudi, and C.R. Bramham Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain Biochem. Soc. Trans. 34 2006 600 604 (Pubitemid 44230773)
41. O. von Bohlen und Halbach Involvement of BDNF in age-dependent alterations in the hippocampus Front Aging Neurosci. 2 2010
42. D.M. Walsh, and D.J. Selkoe Deciphering the molecular basis of memory failure in Alzheimer's disease Neuron 44 2004 181 193 (Pubitemid 39348839)
43. Z. Wang, Q. Liu, R. Zhang, S. Liu, Z. Xia, and Y. Hu Catalpol ameliorates beta amyloid-induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors Neuroscience 163 2009 1363 1372
44. C. Zussy, A. Brureau, B. Delair, S. Marchal, E. Keller, G. Ixart, G. Naert, J. Meunier, N. Chevallier, T. Maurice, and L. Givalois Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid beta fragment in rats Am. J. Pathol. 179 2011 315 334